SECsense Logo

Salarius Pharmaceuticals, Inc. 8-K Report: Key Insights & Updates

$SLRX
Form 8-K
Filed on: 2024-12-23
Source
Salarius Pharmaceuticals, Inc. 8-K Report: Key Insights & Updates

Here are the key insights extracted from the provided financial report section:

  1. Entity Information:
  • Company Name: Salarius Pharmaceuticals, Inc.
  • CIK Number: 0001615219
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 001-36812
  • EIN: 46-5087339
  • Address: 2450 Holcombe Blvd, Suite X, Houston, TX 77021
  • Phone Number: 832-834-6992
  1. Filing Details:
  • Form Type: 8-K (a current report used to notify investors of major events)
  • Filing Date: December 20, 2024
  1. Stock Information:
  • Common Stock Par Value: $0.0001
  • Ticker Symbol: SLRX
  1. Reporting Period:
  • Report Date: September 27, 2024
  • Period Start and End Date: September 27, 2024 (indicating a single-day reporting event)
  1. XBRL Information:
  • The report is formatted in XBRL (eXtensible Business Reporting Language), which is a standard for electronic communication of business and financial data.

Summary:

Salarius Pharmaceuticals, Inc. filed an 8-K report on December 20, 2024, concerning events that occurred on September 27, 2024. The company is based in Houston, Texas, and trades under the ticker symbol SLRX with a par value of $0.0001 for its common stock.